WNK1 Activates SGK1 by a Phosphatidylinositol 3-Kinase-dependent and Non-catalytic Mechanism

Bing-e Xu, Steve Stippec, Ahmed Lazrak, Chou-Long Huang, Melanie H. Cobb

Journal of Biological Chemistry · 2005 · 112 citations · 29 references

DOIFull text

Open access

Concepts

Abstract

WNK1 (with no lysine (K) 1) is a protein-serine/threonine kinase with a unique catalytic site organization. Deletions in the first intron of the WNK1 gene were found in a group of hypertensive patients with pseudohypoaldosteronism type II. No changes in coding sequence of WNK1 were found, but its expression was increased severalfold. We have been investigating actions of WNK1 and have found that WNK1 activates the serum- and glucocorticoid-induced protein kinase SGK1, which impacts membrane expression of the epithelial sodium channel. Here we explore the role of WNK1 in SGK1 regulation. Activation of SGK1 by WNK1 is blocked by phosphatidylinositol 3-kinase inhibitors. Neither the catalytic activity nor the kinase domain of WNK1 is required; rather the N-terminal 220 residues of WNK1 are necessary and sufficient to activate SGK1. Phosphorylation of WNK1 on Thr-58 contributes to SGK1 activation. Finally, we show that WNK1 is required for the activation of SGK1 by insulin-like growth factor 1. WNK1 (with no lysine (K) 1) is a protein-serine/threonine kinase with a unique catalytic site organization. Deletions in the first intron of the WNK1 gene were found in a group of hypertensive patients with pseudohypoaldosteronism type II. No changes in coding sequence of WNK1 were found, but its expression was increased severalfold. We have been investigating actions of WNK1 and have found that WNK1 activates the serum- and glucocorticoid-induced protein kinase SGK1, which impacts membrane expression of the epithelial sodium channel. Here we explore the role of WNK1 in SGK1 regulation. Activation of SGK1 by WNK1 is blocked by phosphatidylinositol 3-kinase inhibitors. Neither the catalytic activity nor the kinase domain of WNK1 is required; rather the N-terminal 220 residues of WNK1 are necessary and sufficient to activate SGK1. Phosphorylation of WNK1 on Thr-58 contributes to SGK1 activation. Finally, we show that WNK1 is required for the activation of SGK1 by insulin-like growth factor 1. WNK1 (with no lysine (K) 1) is a protein-serine/threonine kinase containing over 2,000 residues. It was identified several years ago in PCR screens to find novel components of mitogen-activated protein kinase (MAPK) 2The abbreviations used are: MAPK, mitogen-activated protein kinase; PI, phosphatidylinositol; ERK, extracellular signal-regulated kinase; MEK, mitogen-activated protein kinase/extracellular signal-regulated kinase kinase; MEKK, MEK kinase; ENaC, epithelial sodium channel; IGF-1, insulin-like growth factor 1. cascades (1Xu B. English J.M. Wilsbacher J.L. Stippec S. Goldsmith E.J. Cobb M.H. J. Biol. Chem. 2000; 275: 16795-16801Abstract Full Text Full Text PDF PubMed Scopus (417) Google Scholar). The catalytic lysine in all WNK family members is located in the glycine-rich β strand 2 rather than in the typical position in β strand 3 of the kinase domain, where it is found in all other protein kinases (1Xu B. English J.M. Wilsbacher J.L. Stippec S. Goldsmith E.J. Cobb M.H. J. Biol. Chem. 2000; 275: 16795-16801Abstract Full Text Full Text PDF PubMed Scopus (417) Google Scholar). The crystal structure of the WNK1 kinase domain supports the expected position of the lysine residue that had been deduced from earlier mutagenesis studies (1Xu B. English J.M. Wilsbacher J.L. Stippec S. Goldsmith E.J. Cobb M.H. J. Biol. Chem. 2000; 275: 16795-16801Abstract Full Text Full Text PDF PubMed Scopus (417) Google Scholar, 2Min X. Lee B.H. Cobb M.H. Goldsmith E.J. Structure (Camb.). 2004; 12: 1303-1311Abstract Full Text Full Text PDF PubMed Scopus (161) Google Scholar). WNK1 and WNK4 have been found as genes mutated in pseudohypoaldosteronism type II, a rare form of monogenic hypertension (3Wilson F.H. Disse-Nicodeme S. Choate K.A. Ishikawa K. Nelson-Williams C. Desitter I. Gunel M. Milford D.V. Lipkin G.W. Achard J.M. Feely M.P. Dussol B. Berland Y. Unwin R.J. Mayan H. Simon D.B. Farfel Z. Jeunemaitre X. Lifton R.P. Science. 2001; 293: 1107-1112Crossref PubMed Scopus (1233) Google Scholar). The mutations in WNK1, arising from large deletions in the first intron, do not affect the coding sequence and cause an increase in WNK1 expression. Mice lacking the Wnk1 gene do not develop beyond embryonic day 13 (4Zambrowicz B.P. Abuin A. Ramirez-Solis R. Richter L.J. Piggott J. Beltrandel-Rio H. Buxton E.C. Edwards J. Finch R.A. Friddle C.J. Gupta A. Hansen G. Hu Y. Huang W. Jaing C. Key Jr., B.W. Kipp P. Kohlhauff B. Ma Z.Q. Markesich D. Payne R. Potter D.G. Qian N. Shaw J. Schrick J. Shi Z.Z. Sparks M.J. Van Sligtenhorst I. Vogel P. Walke W. Xu N. Zhu Q. Person C. Sands A.T. Proc. Natl. Acad. Sci. U. S. A. 2003; 100: 14109-14114Crossref PubMed Scopus (303) Google Scholar). However, heterozygous animals show reduced blood pressure, leading to the supposition that the amount of WNK1 expressed will influence blood pressure in both rodents and humans. WNK1 is widely expressed in cell lines and animal tissues, indicating that it acts throughout the body (1Xu B. English J.M. Wilsbacher J.L. Stippec S. Goldsmith E.J. Cobb M.H. J. Biol. Chem. 2000; 275: 16795-16801Abstract Full Text Full Text PDF PubMed Scopus (417) Google Scholar, 3Wilson F.H. Disse-Nicodeme S. Choate K.A. Ishikawa K. Nelson-Williams C. Desitter I. Gunel M. Milford D.V. Lipkin G.W. Achard J.M. Feely M.P. Dussol B. Berland Y. Unwin R.J. Mayan H. Simon D.B. Farfel Z. Jeunemaitre X. Lifton R.P. Science. 2001; 293: 1107-1112Crossref PubMed Scopus (1233) Google Scholar, 5Verissimo F. Jordan P. Oncogene. 2001; 20: 5562-5569Crossref PubMed Scopus (226) Google Scholar). Multiple splice forms have been found, including at least one that lacks the N terminus and that may be enriched in kidney (6Xu Q. Modrek B. Lee C. Nucleic Acids Res. 2002; 30: 3754-3766Crossref PubMed Scopus (315) Google Scholar, 7Delaloy C. Lu J. Houot A.M. Disse-Nicodeme S. Gasc J.M. Corvol P. Jeunemaitre X. Mol. Cell. Biol. 2003; 23: 9208-9221Crossref PubMed Scopus (141) Google Scholar). Both hyper- and hypo-osmotic stresses stimulate the protein kinase activity of WNK1 (8Lenertz L. Lee B.H. Min X. Xu B. Wedin K. Earnest S. Goldsmith E.J. Cobb M.H. J. Biol. Chem. 2005; 280: 26653-26658Abstract Full Text Full Text PDF PubMed Scopus (117) Google Scholar). Several biochemical actions of WNK1 have been discovered. WNK1 can stimulate the activity of the MAPK ERK5 by acting upstream of the MAPK kinase kinases MEKK2 and MEKK3 (9Xu B. Stippec S. Lenertz L. Lee B.H. Zhang W. Lee Y.K. Cobb M.H. J. Biol. Chem. 2004; 279: 7826-7831Abstract Full Text Full Text PDF PubMed Scopus (122) Google Scholar). Stimulation of ERK5 by low nanomolar concentrations of epidermal growth factor requires WNK1. In contrast, WNK1 is not required for activation of ERK5 by the osmotic stresses sorbitol and NaCl, although these agents stimulate WNK1 protein kinase activity. Together with the finding that kinase-deficient mutants of WNK1 also have some ability to activate MEKK3 and ERK5, this raises a question about the importance of WNK1 kinase activity in regulating the ERK5 pathway. Two-hybrid screens with WNK1 have identified two other WNK1 targets. The first of these, synaptotagmin 2, is a WNK1 substrate (10Lee B.H. Min X. Heise C.J. Xu B. Chen S. Shu H. Luby-Phelps K. Goldsmith E.J. Cobb M.H. Mol. Cell. 2004; 15: 741-751Abstract Full Text Full Text PDF PubMed Scopus (66) Google Scholar). Synaptotagmin 2 is involved in Ca2+-dependent interactions with membranes and other proteins that are required for membrane fusion events (11Geppert M. Goda Y. Hammer R.E. Li C. Rosahl T.W. Stevens C.F. Sudhof T.C. Cell. 1994; 79: 717-727Abstract Full Text PDF PubMed Scopus (1223) Google Scholar). WNK1 phosphorylation of synaptotagmin 2 increases the amount of Ca2+ required for its binding to phospholipid vesicles. As a result, phosphorylation of synaptotagmins by WNK1 may enhance the retention or insertion of proteins, including ion transporters, in the plasma membrane. A second WNK1 target found in a two-hybrid screen is the serum- and glucocorticoid-induced protein kinase, SGK1 (12Xu B. Stippec S. Chu P.-Y. Li X.-J. Lazrak A. Ortega B. Lee B.H. English J.M. Huang C.-L. Cobb M.H. Proc. Natl. Acad. Sci. U. S. A. 2005; 102: 10315-10320Crossref PubMed Scopus (166) Google Scholar). SGK1 binds to WNK1 and is strongly activated by WNK1. Significantly, activation of SGK1 by WNK1 leads to an increase in sodium current carried by the epithelial sodium channel (ENaC) reconstituted in Xenopus oocytes and Chinese hamster ovary cells (12Xu B. Stippec S. Chu P.-Y. Li X.-J. Lazrak A. Ortega B. Lee B.H. English J.M. Huang C.-L. Cobb M.H. Proc. Natl. Acad. Sci. U. S. A. 2005; 102: 10315-10320Crossref PubMed Scopus (166) Google Scholar). SGK1 is known to phosphorylate the ubiquitin-protein isopeptide ligase Nedd4-2, preventing it from down-regulating ENaC (13Alvarez d.l.R. Zhang P. Naray-Fejes-Toth A. Fejes-Toth G. Canessa C.M. J. Biol. Chem. 1999; 274: 37834-37839Abstract Full Text Full Text PDF PubMed Scopus (241) Google Scholar, 14Debonneville C. Flores S.Y. Kamynina E. Plant P.J. Tauxe C. Thomas M.A. Munster C. Chraibi A. Pratt J.H. Horisberger J.D. Pearce D. Loffing J. Staub O. EMBO J. 2001; 20: 7052-7059Crossref PubMed Scopus (582) Google Scholar, 15Snyder P.M. Olson D.R. Thomas B.C. J. Biol. Chem. 2002; 277: 5-8Abstract Full Text Full Text PDF PubMed Scopus (389) Google Scholar, 16Rotin D. Curr. Opin. Nephrol. Hypertens. 2000; 9: 529-534Crossref PubMed Scopus (45) Google Scholar). In contrast to SGK1, the related kinase Akt1 is unable to prevent ENaC down-regulation (17Arteaga M.F. Canessa C.M. Am. J. Physiol. 2005; 289: F90-F96Google Scholar). In this study, we examined the mechanism of regulation of SGK1 by WNK1. Similar to control of the ERK5 pathway, activation of SGK1 does not require WNK1 catalytic activity. Materials—Constructs were prepared using standard methods (1Xu B. English J.M. Wilsbacher J.L. Stippec S. Goldsmith E.J. Cobb M.H. J. Biol. Chem. 2000; 275: 16795-16801Abstract Full Text Full Text PDF PubMed Scopus (417) Google Scholar, 9Xu B. Stippec S. Lenertz L. Lee B.H. Zhang W. Lee Y.K. Cobb M.H. J. Biol. Chem. 2004; 279: 7826-7831Abstract Full Text Full Text PDF PubMed Scopus (122) Google Scholar, 18Xu B. Min X. Stippec S. Lee B.H. Goldsmith E.J. Cobb M.H. J. Biol. Chem. 2002; 277: 48456-48462Abstract Full Text Full Text PDF PubMed Scopus (124) Google Scholar). Site-directed mutagenesis was achieved using the QuikChange kit (Stratagene). DNAs were provided as follows: SGK1 and p70, by M. E. Greenberg and J. Blenis, respectively (Harvard University); SGK2 and SGK3, PDK1, and Akt, by Orson Moe, E. N. Olson, and M. A. White, respectively (University of Texas Southwestern Medical Center); Nedd4-2 by P. M. Snyder (University of Iowa); and ENaC α, β, and γ subunits by T. R. Kleyman (University of Pittsburgh). Anti-Myc, anti-hemagglutinin, anti-FLAG, and anti-WNK1 (Q256) were as described. Anti-WNK1 phospho-Thr-58 was prepared by PhosphoSolutions. Akt pT308 and pS473 antibodies were obtained from Cell Signaling. Insulin-like growth factor 1 (IGF-1) was purchased from Calbiochem. Crosstide (GRPRTSSFAEGRR) was synthesized by the institutional peptide synthesis facility. Double-stranded RNA oligonucleotides were obtained from the institutional facility and are as described previously (9Xu B. Stippec S. Lenertz L. Lee B.H. Zhang W. Lee Y.K. Cobb M.H. J. Biol. Chem. 2004; 279: 7826-7831Abstract Full Text Full Text PDF PubMed Scopus (122) Google Scholar). Protein Expression—GST-Nedd4-2 and WNK1-(1-555) were purified from Escherichia coli strain BL21 using standard protocols. Tissue Culture, Cell Treatments, and RNA Interference—HEK293 cells were grown using standard conditions as described previously (19Xu B. Wilsbacher J.L. Collisson T. Cobb M.H. J. Biol. Chem. 1999; 274: 34029-34035Abstract Full Text Full Text PDF PubMed Scopus (96) Google Scholar). Cells were transfected and harvested in isotonic lysis buffer containing 1% Triton X-100 and phosphatase and protease inhibitors as described previously (19Xu B. Wilsbacher J.L. Collisson T. Cobb M.H. J. Biol. Chem. 1999; 274: 34029-34035Abstract Full Text Full Text PDF PubMed Scopus (96) Google Scholar). As indicated in the figure legends, 10 μm U0126 was added to cells 1 h before harvest, 50 nm was added to cells and μm 1 h to harvest, and μm was added to cells h before was added to indicated cells for RNA cells were grown to in and transfected with RNA oligonucleotides as described previously (9Xu B. Stippec S. Lenertz L. Lee B.H. Zhang W. Lee Y.K. Cobb M.H. J. Biol. Chem. 2004; 279: 7826-7831Abstract Full Text Full Text PDF PubMed Scopus (122) Google Scholar). the 1 of SGK1 was transfected and cells were harvested h and Protein were from cell with an of and using protein was on proteins in cell or that had been by and were using In kinase of were as described previously using Nedd4-2 or as (12Xu B. Stippec S. Chu P.-Y. Li X.-J. Lazrak A. Ortega B. Lee B.H. English J.M. Huang C.-L. Cobb M.H. Proc. Natl. Acad. Sci. U. S. A. 2005; 102: 10315-10320Crossref PubMed Scopus (166) Google Scholar). of ENaC for α, β, and γ subunits of ENaC D.R. F. Li J. Kleyman Am. J. Physiol. 1999; 277: PubMed Google WNK1, SGK1, and Nedd4-2 were synthesized using a in kit Xenopus oocytes and were prepared and with for at the indicated concentrations as described previously (12Xu B. Stippec S. Chu P.-Y. Li X.-J. Lazrak A. Ortega B. Lee B.H. English J.M. Huang C.-L. Cobb M.H. Proc. Natl. Acad. Sci. U. S. A. 2005; 102: 10315-10320Crossref PubMed Scopus (166) Google Scholar, Li Huang J. Biol. Chem. 2003; Full Text Full Text PDF PubMed Scopus Google Scholar). oocytes were in containing NaCl, 2 1 1 and h were from oocytes in using an and of from to 50 in from that were carried by sodium was by a containing 1 1 and was using the WNK1 previously that WNK1 activates SGK1 but not the kinases kinase or Akt, in transfected cells (12Xu B. Stippec S. Chu P.-Y. Li X.-J. Lazrak A. Ortega B. Lee B.H. English J.M. Huang C.-L. Cobb M.H. Proc. Natl. Acad. Sci. U. S. A. 2005; 102: 10315-10320Crossref PubMed Scopus (166) Google Scholar). the of are expressed in epithelial tissues, we first to the of WNK1 in family we the ability of WNK1 to activate SGK2 and using the peptide as the We found that these proteins were also by with WNK1, although to a than SGK1 1 and The that all are that WNK1, which is can events in cells that of the of SGK1 by WNK1 is to inhibitors of cells were with 10 μm U0126 for 1 h or 50 nm for to SGK1 activity was with as cells were with μm or with 50 nm for to SGK1 activity was with Nedd4-2 as SGK1 activation by is to cells were with μm for 1 h to SGK1 activity was with as activation of WNK1 by osmotic is to The activity of WNK1 was in as were two to Activation of SGK1 by WNK1 by earlier studies we found that SGK1 is not a substrate of WNK1. to the mechanism by which WNK1 increases SGK1 we the of inhibitors of MAPK 2, A and of WNK1 with SGK1 increases SGK1 activity with Nedd4-2 or the peptide We found previously that WNK1 ERK5 activity and a on MAPK (9Xu B. Stippec S. Lenertz L. Lee B.H. Zhang W. Lee Y.K. Cobb M.H. J. Biol. Chem. 2004; 279: 7826-7831Abstract Full Text Full Text PDF PubMed Scopus (122) Google Scholar). Both of these have been in SGK1 regulation M. Y. Lee J.D. J. Biol. Chem. 2001; Full Text Full Text PDF PubMed Scopus Google Scholar, B. E. J. J. Biol. Chem. 2000; 275: Full Text Full Text PDF PubMed Scopus Google Scholar, S. Mol. 2000; PubMed Scopus Google Scholar, B. J. Biol. Chem. 2003; Full Text Full Text PDF PubMed Scopus Google Scholar). the ERK5 pathway, we used U0126 the kinases upstream of as as ERK5 S. T. E. J. Biol. Chem. 1999; 274: Full Text Full Text PDF PubMed Scopus Google Scholar). We found that U0126 had no on the activation of SGK1 by WNK1 which is with that mutants of MEKK2 and not SGK1 activation by WNK1 (12Xu B. Stippec S. Chu P.-Y. Li X.-J. Lazrak A. Ortega B. Lee B.H. English J.M. Huang C.-L. Cobb M.H. Proc. Natl. Acad. Sci. U. S. A. 2005; 102: 10315-10320Crossref PubMed Scopus (166) Google Scholar). the had no on the activation of SGK1 by WNK1 The 3-kinase the activation of SGK1 by a of including B. J. Biol. Chem. 2003; Full Text Full Text PDF PubMed Scopus Google Scholar). we the of and found that it reduced the activation of SGK1 by WNK1 2, A and In of an earlier T. P. J. 1999; PubMed Scopus Google Scholar, J. P. EMBO J. 1999; PubMed Scopus Google we also found that the activation of SGK1 by is not indicating that this was not the site of of Activation of SGK1 by WNK1 was also blocked by 3-kinase Activation of SGK1 by WNK1 be by the activation of WNK1 is this we examined the of on the activation of WNK1 by osmotic the known type of WNK1 WNK1 was by was no of on its activation. WNK1 activation was also not a site of 3-kinase Activation of SGK1 and ENaC by WNK1 was identified as a protein kinase that Akt in a SGK1 is by of 3-kinase T. P. J. 1999; PubMed Scopus Google we the that 3-kinase an required for the activation of SGK1 by WNK1 the 3-kinase kinase A of Akt reduced SGK1 activation by WNK1, a of the related kinase had no that activation of SGK1 by WNK1 requires the catalytic activity of ENaC subunits were identified by expression in Xenopus oocytes C.M. L. G. B. I. Horisberger J.D. B.C. 1994; PubMed Scopus Google Scholar). ENaC activity can be by in the to the of ENaC with WNK1 in oocytes ENaC activity (12Xu B. Stippec S. Chu P.-Y. Li X.-J. Lazrak A. Ortega B. Lee B.H. English J.M. Huang C.-L. Cobb M.H. Proc. Natl. Acad. Sci. U. S. A. 2005; 102: 10315-10320Crossref PubMed Scopus (166) Google Scholar). We have previously that of ENaC by WNK1 activation of in oocytes (12Xu B. Stippec S. Chu P.-Y. Li X.-J. Lazrak A. Ortega B. Lee B.H. English J.M. Huang C.-L. Cobb M.H. Proc. Natl. Acad. Sci. U. S. A. 2005; 102: 10315-10320Crossref PubMed Scopus (166) Google Scholar). Akt the of WNK1 on ENaC activity with its on SGK1 activation by WNK1. WNK1 not activate Akt, Akt acts upstream or in with WNK1. Activation of SGK1 by WNK1 by Phosphorylation of WNK1 Thr-58 been to be an site of Akt phosphorylation M. N. A. S. D.R. J. 2004; PubMed Scopus Google Scholar, J. S. J. K. M. M.P. J. Biol. Chem. 2005; 280: Full Text Full Text PDF PubMed Scopus Google We found that Akt as as SGK1 WNK1 in of WNK1 Thr-58 to reduced phosphorylation by Akt and also reduced phosphorylation by SGK1, that SGK1 WNK1 not on Thr-58 but also on an phospho-Thr-58 of WNK1, we found that was on Thr-58 in cells and reduced its phosphorylation and were in SGK1 with type WNK1 although activation of SGK1 was that phosphorylation of Thr-58 by Akt or other kinases as enhance the activation of SGK1 by WNK1. the activation of Akt requires the activation of SGK1 by WNK1 requires 3-kinase activity to WNK1 Thr-58 phosphorylation by The phosphorylation of WNK1 by SGK1 may WNK1 SGK1 and ENaC by a of of Thr-58 the ability of WNK1 to activate SGK1, we the N-terminal of WNK1 containing Thr-58 is required for SGK1 activation. We found that not was the catalytic activity of WNK1 for its ability to activate SGK1 but the catalytic domain was also A and which Thr-58 and residues the kinase domain, was sufficient to activate SGK1 We the of these biochemical to increased sodium current and found that a activation of ENaC, the kinase domain lacking the N-terminal residues had no with using of Thr-58 reduced activation of SGK1 by of Thr-58 reduced the ability of and to activate ENaC that the N terminus of WNK1, on is of SGK1 and ENaC of WNK1 catalytic activation of ENaC is on its N residues of WNK1 are sufficient for the of ENaC phosphorylation of Thr-58 is required for the activation of ENaC were at least WNK1 for Activation of SGK1 by we have that WNK1 is sufficient to activate SGK1. WNK1 is necessary for SGK1 activation by we WNK1 expression by RNA and examined SGK1 activity In the of WNK1, to increase in SGK1 activity. WNK1 expression was reduced by using RNA to activate SGK1 is that WNK1 is required for SGK1 activation by As a control to that had not been we also examined the activation of Akt in the As in Akt as indicated by and was not by the of WNK1. WNK1 activates the protein kinase SGK1 in a that leads to increased sodium (12Xu B. Stippec S. Chu P.-Y. Li X.-J. Lazrak A. Ortega B. Lee B.H. English J.M. Huang C.-L. Cobb M.H. Proc. Natl. Acad. Sci. U. S. A. 2005; 102: 10315-10320Crossref PubMed Scopus (166) Google Scholar). of WNK1 is sufficient to activate SGK1, and expression of WNK1 is required for the of SGK1 activity by Activation by WNK1 requires phosphorylation of SGK1. WNK1 binds SGK1 WNK1 does not phosphorylate we have other of SGK1 activation. no to MAPK WNK1 some to the of which activate MAPK kinase kinases by phosphorylation or WNK1, some to activate the MAPK kinase kinase We that MEKK3 is not involved in SGK1 activation (12Xu B. Stippec S. Chu P.-Y. Li X.-J. Lazrak A. Ortega B. Lee B.H. English J.M. Huang C.-L. Cobb M.H. Proc. Natl. Acad. Sci. U. S. A. 2005; 102: 10315-10320Crossref PubMed Scopus (166) Google Scholar). and ERK5, both of which can be activated by have been in the regulation of SGK1 in M. Y. Lee J.D. J. Biol. Chem. 2001; Full Text Full Text PDF PubMed Scopus Google Scholar, B. E. J. J. Biol. Chem. 2000; 275: Full Text Full Text PDF PubMed Scopus Google Scholar, S. Mol. 2000; PubMed Scopus Google Scholar). We that of these nor are involved in SGK1 activation by WNK1. that the 3-kinase is for WNK1 3-kinase activity is not required to activate the kinase activity of WNK1 of 3-kinase does not with the activation of WNK1 by osmotic However, Akt does phosphorylate WNK1 on a site that or no on the kinase activity of WNK1 M. N. A. S. D.R. J. 2004; PubMed Scopus Google Scholar, J. S. J. K. M. M.P. J. Biol. Chem. 2005; 280: Full Text Full Text PDF PubMed Scopus Google Scholar). We that phosphorylation of WNK1 Thr-58 by Akt is the in the mechanism the activation of SGK1. on SGK1 Akt, it is activated by phosphorylation on the two described phosphorylation a residue in the activation of SGK1 and a second site in a SGK1 J. P. EMBO J. 1999; PubMed Scopus Google Scholar). We found that activation of SGK1 by WNK1 required phosphorylation of these two is to be the activation kinase on biochemical T. P. J. 1999; PubMed Scopus Google Scholar, J. P. EMBO J. 1999; PubMed Scopus Google Scholar). The for the other SGK1 site is and WNK1 may not have a on although the of SGK1 was than the type it the ability to be activated by with WNK1 (12Xu B. Stippec S. Chu P.-Y. Li X.-J. Lazrak A. Ortega B. Lee B.H. English J.M. Huang C.-L. Cobb M.H. Proc. Natl. Acad. Sci. U. S. A. 2005; 102: 10315-10320Crossref PubMed Scopus (166) Google Scholar). that WNK1 is involved in phosphorylation of the SGK1 activation the of we that WNK1 and to activate SGK1 mechanism is unique to family members and is not involved in regulating related kinases as A is involved not at the of but of a for phosphorylation of WNK1 on In this SGK1 activation by WNK1 phosphorylation on this In the role of Thr-58 does not the that are components required for SGK1 activation. Thr-58 phosphorylation of WNK1 SGK1 activation is not WNK1 binds to SGK1, WNK1 may as a to a protein required for SGK1 activation. may a binding site for proteins involved in SGK1 activation or a in SGK1 that is for its activation. we have been unable to SGK1 activation in or in by WNK1 it that components are necessary to SGK1 activation. A screen of phosphorylation that WNK1 Thr-58 may also be a substrate for protein kinase, and protein kinase II, several protein kinase and family for the phosphorylation on WNK1 Thr-58 in cells with to 3-kinase and may other to SGK1 activation and the activation of SGK1 may a mechanism to enhance its activation by WNK1 on We and Lee for about this and for

References

29